Sami Deniz

Clinical factors and comorbidities affecting the cost of hospital-treated COPD

Purpose We aimed to assess the effects of comorbidities on COPD costs and to investigate the relationship between comorbidities and clinical variables. Patients and methods All patients hospitalized with a diagnosis of COPD exacerbation between January 1, 2014, and December 31, 2014, at all state hospitals of Aydın province, a city located in the western part of Turkey, were included in this study. The costs examined in the study pertained to medications, laboratory tests, hospital stays, and other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees. Results A total of 3,095 patients with 5,237 exacerbations (mean age, 71.9±10.5 years; 2,434 males and 661 females) were evaluated. For 880 of the patients (28.9%), or 3,852 of the exacerbations (73.1%), at least one comorbid disease was recorded. The mean cost of each exacerbation was

Pneumomediastinum after Endobronchial Ultrasound–Guided Transbronchial Needle Aspiration: A case report

808.5±1,586, including

Factors affecting TST level in patients undergoing dialysis: a multicenter study: Factors affecting TST level in CKD

325.1±879.9 (40.7%) for hospital stays,

Comparison of the Fractional Exhaled Nitric Oxide Levels in Adolescents at Three Schools Located Three Different Distances from a Large Steel Mill

223.1±1,300.9 (27.6%) for medications,

Adherence to Current COPD Guidelines in Turkey

46.3±49.6 (0.9%) for laboratory expenditures, and

Two-Years Follow-up Results of a Smoking Cessation Clinic in a State Hospital

214±1,068 (26.5%) for other treatment-related factors, such as consumption of materials, doctor visits, and consultation fees. The cost of each exacerbation was

Clinical Factors Affecting the Costs of Hospitalized Chronic Obstructive Pulmonary Disease Exacerbations

1,014.9 in patients with at least one comorbidity, whereas it was

In Which the Gain is more from PR? Asthma or COPD? Short title: Pulmonary Rehabilitation in COPD and Asthma

233.6 in patients without comorbidity (P<0.001). Age >65 years, female gender, hospitalization in an intensive care unit, invasive or noninvasive mechanical ventilation, and a long duration of hospitalization were all found to be significant factors in increasing total costs during the exacerbations requiring hospitalization (P<0.05 for all). Conclusion Comorbidities have an important role in the total costs of acute exacerbations of COPD. Strategies for the prevention, diagnosis, and effective management of comorbidities would decrease the overall financial burden associated with acute exacerbations of COPD.

Affect of conviction on life span in lung cancer

Pneumomediastinum is defined as an abnormal accumulation of air within the mediastinum. It occurs most often when increased alveolar pressure leads to alveolar rupture, and less frequently when there is perforation of the tracheobronchial tree. Pressure gradients then allow air to spread via the fascia to the surrounding soft tissues, mediastinum, and/or retroperitoneum. This is a report of a case of pneumomediastinum following endobronchial ultrasound– guided fine needle aspiration (EBUS/TBNA) of the mediastinal lymph nodes, widely regarded as a safe procedure.

May Biochemical Variables and Pleural Fluid Cell Count Be Used in The Benign-Malign Differentiation of Pleural Effusions Associated with Lung Cancer?

Introduction: The risk of TB is increased in patients with chronic kidney disease (CKD) when compared with individuals with normal renal function. We aimed to determine tuberculin skin test (TST) response and the factors which might affect the response in patients with CKD undergoing dialysis in this study.